Cystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid

[1]  J. Goldberg,et al.  Role of Mutant CFTR in Hypersusceptibility of Cystic Fibrosis Patients to Lung Infections , 1996, Science.

[2]  J. Wine.  Cystic Fibrosis: How do CFTR mutations cause cystic fibrosis? , 1995, Current Biology.

[3]  J. Pilewski,et al.  How do cystic fibrosis transmembrane conductance regulator mutations produce lung disease? , 1995, Current opinion in pulmonary medicine.

[4]  T. Ganz,et al.  Defensins and other endogenous peptide antibiotics of vertebrates , 1995, Journal of leukocyte biology.

[5]  M. Weinberger,et al.  The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis , 1995, Pediatric pulmonology.

[6]  P. Thorne,et al.  Bioaerosol Concentrations in Noncomplaint, Complaint, and Intervention Homes in the Midwest , 1995 .

[7]  D. Riches,et al.  Early pulmonary inflammation in infants with cystic fibrosis. , 1995, American journal of respiratory and critical care medicine.

[8]  A. Prince,et al.  Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  F. Ognibene,et al.  Tumor necrosis factor-alpha induces mucin hypersecretion and MUC-2 gene expression by human airway epithelial cells. , 1995, American journal of respiratory cell and molecular biology.

[10]  D. Bailey,et al.  Mucociliary clearance in patients with cystic fibrosis and in normal subjects. , 1994, American journal of respiratory and critical care medicine.

[11]  Alan E. Smith,et al.  Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: efficiency of adenovirus-mediated gene transfer in vitro. , 1994, Human gene therapy.

[12]  M. Welsh,et al.  Expression of cystic fibrosis transmembrane conductance regulator in a model epithelium. , 1994, The American journal of physiology.

[13]  M. Welsh,et al.  Defective fluid transport by cystic fibrosis airway epithelia. , 1994, The Journal of clinical investigation.

[14]  P. Quinton,et al.  Elemental composition of human airway surface fluid in healthy and diseased airways. , 1993, The American review of respiratory disease.

[15]  J. Widdicombe,et al.  Altered fluid transport across airway epithelium in cystic fibrosis. , 1993, Science.

[16]  A. Prince,et al.  Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. , 1993, The Journal of clinical investigation.

[17]  Douglas E. Jones,et al.  Airway epithelial cells are the site of expression of a mammalian antimicrobial peptide gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Welsh,et al.  Fluid and electrolyte transport by cultured human airway epithelia. , 1993, The Journal of clinical investigation.

[19]  M. Yamaya,et al.  Differentiated structure and function of cultures from human tracheal epithelium. , 1992, The American journal of physiology.

[20]  F. Collins,et al.  Cystic fibrosis: molecular biology and therapeutic implications. , 1992, Science.

[21]  M. Knowles,et al.  Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. , 1991, The New England journal of medicine.

[22]  R. Gibson,et al.  Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients. , 1991, The American review of respiratory disease.

[23]  S. Douglas,et al.  Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. , 1990, The American review of respiratory disease.

[24]  P. Quinton.  Cystic fibrosis: a disease in electrolyte transport , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  M. King,et al.  A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. , 1990, The New England journal of medicine.

[26]  B. Strandvik,et al.  Increased bronchial chloride concentration in cystic fibrosis. , 1989, Scandinavian journal of clinical and laboratory investigation.

[27]  A. M. Johnson.  LUNG DISEASE IN CYSTIC FIBROSIS , 1983, The Lancet.

[28]  R. Matthay,et al.  Cystic fibrosis pseudomonas opsonins. Inhibitory nature in an in vitro phagocytic assay. , 1981, The Journal of clinical investigation.

[29]  K. Pierce,et al.  Pharyngeal aspiration in normal adults and patients with depressed consciousness. , 1978, The American journal of medicine.

[30]  H. Levison,et al.  Mucociliary transport in trachea of patients with cystic fibrosis. , 1976, Archives of disease in childhood.

[31]  M. Newhouse,et al.  Pulmonary mucociliary clearance in cystic fibrosis. , 1973, The New England journal of medicine.

[32]  P. Quinton.  Viscosity versus composition in airway pathology. , 1994, American journal of respiratory and critical care medicine.

[33]  J. Shelhamer,et al.  Airway inflammation and mucous hypersecretion , 1994 .

[34]  P. Davis.  Pathophysiology of the lung disease in cystic fibrosis , 1993 .

[35]  M. Konstan,et al.  Infection and inflammation of the lung in cystic fibrosis , 1993 .

[36]  R I Lehrer,et al.  Defensins: antimicrobial and cytotoxic peptides of mammalian cells. , 1993, Annual review of immunology.

[37]  J. Riordan,et al.  The cystic fibrosis transmembrane conductance regulator. , 1993, Annual review of physiology.

[38]  James M. Wilson,et al.  Submucosal glands are the predominant site of CFTR expression in the human bronchus , 1992, Nature Genetics.